Table 1 Patient characteristics
From: Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Item | Mean value/No. of patients | % |
|---|---|---|
Gender | ||
Male | 26 | 57 |
Female | 20 | 43 |
Mean age | 58.6 [33.2-73] years | |
Mean Karnofsky performance index | 81% [60-100%] | |
Localization | ||
frontal | 10 | 22 |
temporal | 26 | 56 |
parietal | 5 | 11 |
occipital | 3 | 7 |
basal ganglia | 1 | 2 |
multifocal | 1 | 2 |
Mean diameter of tumour | 4.3 [1.5-8.0] cm | |
Size of edema | ||
none | 5 | 11 |
< 1 cm | 6 | 13 |
> 1 cm | 15 | 33 |
half hemisphere | 18 | 39 |
total hemisphere | 2 | 4 |
Pre-treatment | ||
complete resection | 27 | 59 |
subtotal resection | 5 | 11 |
partial resection | 12 | 26 |
biopsy | 2 | 4 |
Corticoid intake (beginning of therapy) | ||
None | 0 | 0 |
< 5 mg/day | 1 | 2 |
< 10 mg/day | 14 | 30 |
< 20 mg/day | 21 | 46 |
< 30 mg/day | 2 | 4 |
> 30 mg/day | 8 | 18 |